Table 1.
References | Anesthetic Agent/Adjuvants | Species | Model | Pathway | Effects |
---|---|---|---|---|---|
[8] | Isoflurane | Mice | Endovascular perforation | SphK, S1P1 ↑ | Reduced brain water content, decreased neuronal apoptosis, improved neurological score. |
[9] | Isoflurane | Mice | Endovascular perforation | SphK, S1P1 ↑ | Improved neurological score, brain edema, BBB permeability and prevented the decrease in expressions of tight junction (occludin, JAM-A and claudin-5) and adherens junction (VE- cadherin) proteins. |
[10] | Isoflurane | Mice | Endovascular perforation | SphK, S1P1 ↑ | Improved neurological score, brain edema, BBB permeability and decreased neuroinflammation (↓ MPO, iba-1, IL-1β, TNF-α, P-selectin, ICAM-1, p-JNK and COX-2). |
[12] | Sevoflurane | Mice | Endovascular perforation | - | Improved neurological scores, reduced cerebral edema and apoptosis. |
[13] | Sevoflurane/Isoflurane | Mice | Endovascular perforation | SphK 1 ↑, COX-2 ↓, Caspase -3 ↓ | Both anesthetics attenuated cerebral edema, cell death, improved neurobehavioral function. |
[14] | Sevoflurane/Propofol | Rat | Endovascular perforation | Stabilizing Beta Catenin | Sevoflurane attenuated cerebral edema. |
[15] | Argon | Rat | Endovascular perforation | HIF-1 α ↑, HO-1 ↑ | Reduced mortality and functional outcome improved as measured by the weight of the animals. |
[16] | Xenon | Rat | Endovascular perforation | - | Hippocampal protection, reduction in microglial activity. |
[17] | Xenon | Rat | Endovascular perforation | - | reduced hematoma volume, prevented neuronal cell death, improved neurological function and decreased the mortality and morbidity. |
[18] | Propofol | Rat | Endovascular perforation | Nrf2 ↑, NF-kB ↓, AQP4 ↓, MMP-9 ↓, COX-2 | Reduces cerebral edema, BBB permeability, improves Neuroscore. |
[19] | Propofol | Rat | Endovascular perforation | ↑ PI3K/Akt | Reduces cerebral edema, BBB permeability, improves Neuroscore. |
[21] | Dexmedetomidine | Rat | Endovascular perforation | ERK ↑ | Reduced cerebral edema, BBB permeability, improved neuroscore. |
[22] | Dexmedetomidine | Rat | Endovascular perforation | TLR4/ NF-kB ↓, NLRP3 ↓ | Reduced cerebral edema, BBB permeability, neuronal apoptosis, inhibits neuroinflammation and improves neuroscore. |
[23] | Salvinorin A | Rat | Endovascular perforation | ↑ PI3K/Akt | Attenuated cerebral edema and neuronal apoptosis. |
↑ = Activation/Increase/elevation, ↓ = Inhibition/blockade/decrease, EBI = early brain injury, BBB = blood–brain barrier, OGD = oxygen glucose deprivation, SphK = Sphingosine kinase, S1P1 = Sphingosine-1-phosphate receptor, MPO = myeloperoxidase, iba-1 = Ionized calcium binding adaptor molecule-1, p-JNK = phospho-c-Jun N-terminal kinase, IL-1β = interleukin-1 beta, TNF-α = tumor necrosis factor-alpha, ICAM-1 = intercellular adhesion molecule-1, COX-2 = cyclooxygenase-2, HIF-1 = hypoxia inducible factor, Nrf2 = Nuclearfactorerythroid-relatedfactor2, NF-kB = Nuclear factor-kappa B, AQP4 = aquaporin, MMP-9 = matrix metalloproteinase, ERK = extracellular signal—regulated kinase, PI3K/Akt = Phosphatidylinositol 3-kinase/Akt, TLR4 = Toll-like receptor 4, NLRP3 = nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3.